2024-03-29T01:32:48Z
https://www.bjbms.org/ojs/index.php/bjbms/oai
oai:ojs2.www.bjbms.org:article/506
2021-03-17T19:07:15Z
bjbms:COM
driver
Comment on "Structural changes in the rat placenta during the last third of gestation discovered by stereology"
Lelic, Melisa
Sadiković, Azra
Konrad-Čustović, Maja
Zerem, Enver
Stereology
sampling
placenta
Association of Basic Medical Sciences of FBIH
2015-08-02
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/506
10.17305/bjbms.2015.506
Biomolecules and Biomedicine; Vol. 15 No. 3 (2015); 80
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/506/157
https://www.bjbms.org/ojs/index.php/bjbms/article/view/506/2106
Copyright (c) 2015 Bosnian Journal of Basic Medical Sciences
oai:ojs2.www.bjbms.org:article/667
2021-03-17T19:13:19Z
bjbms:COM
driver
Reply to comment on "Structural changes in the rat placenta during the last third of gestation discovered by stereology"
Serman, Ljiljana
Žunić, Iris
Vrsaljko, Nina
Grbeša, Đurđica
Gjurčević, Emil
Matašin, Željka
Nikuševa Martić, Tamara
Bulić Jakuš, Floriana
Tlak Gajger, Ivana
Šerman, Alan
stereology
sampling
placenta
Association of Basic Medical Sciences of FBIH
2015-08-02
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/667
10.17305/bjbms.2015.667
Biomolecules and Biomedicine; Vol. 15 No. 3 (2015); 81
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/667/158
https://www.bjbms.org/ojs/index.php/bjbms/article/view/667/2107
Copyright (c) 2015 Bosnian Journal of Basic Medical Sciences
oai:ojs2.www.bjbms.org:article/2682
2019-03-26T14:04:39Z
bjbms:COM
driver
Retraction: Evaluation of carcinogenic effects of electromagnetic fields (EMF)
Mehić, Bakir
The Editor-in-chief of the Bosnian Journal of Basic Medical Sciences has decided to retract the article from Bayazit V et al. [1] entitled as: “Evaluation of carcinogenic effects of electromagnetic fields (EMF)” published in Bosn J Basic Med Sci. 2010 Aug;10(3):245-50.After the editorial office was alerted of possible plagiarism in the article, it conducted thorough investigation and concluded that the article apparently represents plagiarized material from two World Health Organization reports, one European Commission report and other sources. Since this is considered scientific plagiarism and scientific misconduct, Editor-in-chief has decided to withdraw the article. The authors have agreed with the editorial office decision.
Association of Basic Medical Sciences of FBIH
2010-11-20
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
https://www.bjbms.org/ojs/index.php/bjbms/article/view/2682
10.17305/bjbms.2010.2682
Biomolecules and Biomedicine; Vol. 10 No. 4 (2010); 331
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/2682/565
Copyright (c) 2017 Bosnian Journal of Basic Medical Sciences
oai:ojs2.www.bjbms.org:article/2696
2019-03-26T14:11:38Z
bjbms:COM
driver
Retraction: Evaluation of Carcinogenic Effects of Electromagnetic Fields (Emf)
Mehic, Bakir
This retracts the article "EVALUATION OF CARCINOGENIC EFFECTS OF ELECTROMAGNETIC FIELDS (EMF)" on page 245. The Editor-in-chief of the Bosnian Journal ofBasic Medical Sciences has decided to retract the article from Bayazit V et al. [1] entitled as: “Evaluation of carcinogenic effects of electromagnetic fields (EMF)” published in Bosn J Basic Med Sci. 2010 Aug;10(3):245-50.After the editorial office was alerted of possible plagiarism in the article, it conducted thorough investigation and concluded that the article apparently represents plagiarized material from two World Health Organization reports, one European Commission report and other sources. Since this is considered scientific plagiarism and scientific misconduct, Editor-in-chief has decided to withdraw the article. The authors have agreed with the editorial office decision.
Association of Basic Medical Sciences of FBIH
2010-08-20
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
https://www.bjbms.org/ojs/index.php/bjbms/article/view/2696
10.17305/bjbms.2010.2696
Biomolecules and Biomedicine; Vol. 10 No. 3 (2010); 331
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/2696/577
Copyright (c) 2017 Bosnian Journal of Basic Medical Sciences
oai:ojs2.www.bjbms.org:article/3507
2020-07-29T09:34:40Z
bjbms:COM
driver
Cloning--philosophical, ethical and religious considerations
Karić, Enes
cloning
philosophical
ethical
religious
consideration
Human cloning is considered in theological and philosophical circles largely from the ethical standpoint. The arguments against human cloning in this type of contemporary theological and philosophical apologetics generally focus on three criteria which, it is claimed, the advocates of human cloning fail to take into consideration. These are: a) moderation, b) limits, c) the entity as a whole. Permit me to set out in brief the main points of reference on which the arguments are based, in the same order.
Association of Basic Medical Sciences of FBIH
2003-08-20
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
https://www.bjbms.org/ojs/index.php/bjbms/article/view/3507
10.17305/bjbms.2003.3507
Biomolecules and Biomedicine; Vol. 3 No. 3 (2003); 15-18
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/3507/1044
Copyright (c) 2018 Bosnian Journal of Basic Medical Sciences
oai:ojs2.www.bjbms.org:article/4847
2021-03-19T21:00:57Z
bjbms:COM
driver
Lessons learned from COVID-19 pandemic in Italy – A commentary
Minni, Antonio
Ralli, Massimo
Candelori, Francesca
Cialente, Fabrizio
Ercoli, Lucia
Parlapiano, Claudio
Greco, Antonio
de Vincentiis, Marco
COVID-19
SARS-CoV-2
early diagnosis
prevention
pandemic
Since the COVID-19 outbreak, Italy has been one of the most affected countries in Europe and the second for number of deaths. In this commentary, we discuss some lessons that we learned as health-care providers working in a large public hospital during the pandemic, with a special focus on the importance of infection containment and early diagnosis, the role of swab, serological tests, home isolation and individual protection devices, and the available therapies and management indications to better face a possible new outbreak in the near future. These comments should stimulate a more diffused, efficient, and efficacious management of COVID-19 patients, also reducing the number of admissions to hospital emergency departments and the related spread of the infection.
Association of Basic Medical Sciences of FBIH
2021-02-01
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/4847
10.17305/bjbms.2020.4847
Biomolecules and Biomedicine; Vol. 21 No. 1 (2021); 117-119
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/4847/1330
https://www.bjbms.org/ojs/index.php/bjbms/article/view/4847/1905
Copyright (c) 2020 Antonio Minni, Massimo Ralli, Francesca Candelori, Fabrizio Cialente, Lucia Ercoli, Claudio Parlapiano, Antonio Greco, Marco de Vincentiis
oai:ojs2.www.bjbms.org:article/5236
2021-07-19T20:25:20Z
bjbms:COM
driver
Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? A commentary
Bedel, Cihan
Korkut, Mustafa
Armağan, Hamit Hakan
Pulmonary embolism
neutrophil-lymphocyte ratio
NLR
platelet-lymphocyte ratio
lymphocyte-monocyte ratio
LMR
prognosis
We read with great interest the article “Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism” by Köse et al.[1]. They found that the neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR) were related to the prognosis and clinical severity of patients with pulmonary embolism (PE). First of all, we congratulate the authors for their invaluable contribution to literature. However, we think that some points should be discussed regarding the use of these laboratory parameters.
White blood cell subtypes NLR, PLR, and LMR, have been associated with many inflammatory diseases, including PE [2,3]. These parameters, which can be easily determined by simple and easy measurement of systemic inflammation, maintain their importance today. However, these parameters are affected by many factors such as trauma, local or systemic infection, acute coronary syndromes, and malignancy [3-5]. For these reasons, it would be better for the authors to mention these factors and exclude them from the tables that included malignancy and trauma patients in the study.
It is known that drugs, including steroids, can increase neutrophils and decrease lymphocytes and therefore affect NLR, PLR, and LMR values [6]. Consequently, it will be more valuable to exclude patients who use drugs that may affect laboratory parameters. Besides, plasma inflammatory biomarkers are time-dependent variables. The time of sample collection and the time from the onset of the symptom to the sampling may impact the parameters [3-6]. Therefore, it is essential to identify the time from the first symptom to sample collection and the factors that may affect it. In conclusion, because NLR, PLR, and LMR can be affected by many factors, prospective studies with large populations are needed to show the accuracy of use in critically ill patients.
Association of Basic Medical Sciences of FBIH
2021-08-01
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5236
10.17305/bjbms.2020.5236
Biomolecules and Biomedicine; Vol. 21 No. 4 (2021); 501
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5236/1626
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5236/2347
Copyright (c) 2020 Cihan Bedel, Mustafa Korkut, Hamit Hakan Armağan
oai:ojs2.www.bjbms.org:article/5292
2021-07-19T20:25:20Z
bjbms:COM
driver
Can NLR, PLR and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary
Kose, Nuri
Yıldırım, Tarık
Akın, Fatih
Elçim Yıldırım, Seda
Altun, Ibrahim
neutrophil-lymphocyte-ratio
platelet-lymphocyte-ratio
monocyte-lymphocyte-ratio
NLR
PLR
MLR
We appreciate the comments made by Dr Bedel and colleagues. NLR, PLR and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Because of this, we have listed some of the above-mentioned disorders in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were therefore excluded from the study. However, the presence of malignancy did not affect our results in regression analysis.Platelets swell until 120 minutes in ethylene diamine tetra acetic (EDTA) and until 60 minutes in citrate [2]. Authors suggest that optimal measuring time should not exceed 120 minutes. The blood samples of the patients were taken within 1 hour after their emergency admission. All blood samples in our study were tested within 1 hour of collection [3]. We used EDTA for whole blood anticoagulation. The mean duration of symptoms prior to admission was 5.04 ± 6.9 days. The drugs such as corticosteroids affect inflammatory parameters. Therefore, we excluded inflammatory diseases without emphasizing corticosteroids or other anti-inflammatory drugs.
Association of Basic Medical Sciences of FBIH
2021-08-01
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5292
10.17305/bjbms.2020.5292
Biomolecules and Biomedicine; Vol. 21 No. 4 (2021); 502
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5292/1627
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5292/2348
Copyright (c) 2020 Nuri Kose, Tarık Yıldırım, Fatih Akın, Seda Elçim Yıldırım, Ibrahim Altun
oai:ojs2.www.bjbms.org:article/5939
2021-10-29T08:35:14Z
bjbms:COM
driver
Letter regarding “Chronic mechanical irritation and oral squamous cell carcinoma: A systematic review and meta-analysis”
Xie, Jian
Li, Lang
letter
oral squamous cell carcinoma
mechanical irritation
Dear Editor:
We have read with a great interest the article by Gupta et al. [1] who performed a meta-analysis exploring the association between chronic mechanical irritation and oral squamous cell carcinoma. The conclusion of the meta-analysis is that chronic oral mucosa irritation has a significant association with oral squamous cell carcinoma, and the nature of association could be that of a potential co-factor (dependent risk factor) rather than an independent risk factor.
Read more in PDF.
Association of Basic Medical Sciences of FBIH
2021-12-01
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5939
10.17305/bjbms.2021.5939
Biomolecules and Biomedicine; Vol. 21 No. 6 (2021); 788
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5939/2187
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5939/2408
Copyright (c) 2021 Jian Xie, Lang Li
oai:ojs2.www.bjbms.org:article/6006
2021-10-29T08:34:49Z
bjbms:COM
driver
Reply to the letter regarding “Chronic mechanical irritation and oral squamous cell carcinoma: A systematic review and meta-analysis”
Gupta, Archana A
Kheur, Supriya
Varadarajan, Saranya
Parveen, Sameena
Dewan, Harisha
Alhazmi, Yaser Ali
Raj, A. Thirumal
Testarelli, Luca
Patil, Shankargouda
Oral squamous cell carcinoma
risk factor
differences in risk factors
Dear Editor,
We thank Dr. Jian Xie for the valuable inputs on our paper titled ‘Chronic mechanical irritation and oral squamous cell carcinoma: A systematic review and meta-analysis [1].’ The first concern of Dr. Xie was that we had included two studies that were based on the same population. We re-examined these papers, one was published in 2010 [2] and the other in 2017 [3] by the same group of authors. Given the significant time difference between the two papers, we did not want to presume they were from the same sample population. There is no clear evidence that they are from the same sample population.
Read more in PDF.
Association of Basic Medical Sciences of FBIH
2021-12-01
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/6006
10.17305/bjbms.2021.6006
Biomolecules and Biomedicine; Vol. 21 No. 6 (2021); 787
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/6006/2188
https://www.bjbms.org/ojs/index.php/bjbms/article/view/6006/2407
Copyright (c) 2021 Archana A Gupta, Supriya Kheur, Saranya Varadarajan, Sameena Parveen, Harisha Dewan, Yaser Ali Alhazmi, A. Thirumal Raj, Luca Testarelli, Shankargouda Patil
oai:ojs2.www.bjbms.org:article/6419
2022-04-01T15:56:01Z
bjbms:COM
driver
Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature
Chen, Zhe-Sheng
Yang, Dong-Hua
Early-stage extranodal natural killer/T-cell lymphoma
treatment modality
single nuceotide polymorphism
The therapeutic modalities of early-stage and advanced extranodal natural killer/T-cell lymphoma (NKTCL) patients are completely different. The former is mainly radiotherapy with or without chemotherapy, while the latter relies on chemotherapy-based systemic treatment. According to Ann Arbor staging system, approximately 70% of the NKTCL patients are classified as early-stage cases who are promising to be cured.Considering NKTCL is sensitive to radiation but may be resistant to chemotherapy, the radiotherapy is considered to be the most important treatment for some early-stage patients with a satisfactory local control rate and could be used alone. However, systemic recurrence after radiotherapy in a portion of NKTCL patients seriously affects their long-term survival, and the first-line treatment combined with radiotherapy and chemotherapy is considered necessary. Therefore, the use of radiotherapy alone in early-stage NKTCL is still a controversial issue.
Read more in PDF.
Association of Basic Medical Sciences of FBIH
2022-04-01
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/6419
10.17305/bjbms.2021.6419
Biomolecules and Biomedicine; Vol. 22 No. 2 (2022); 300-301
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/6419/2372
https://www.bjbms.org/ojs/index.php/bjbms/article/view/6419/2486
Copyright (c) 2021 Zhe-Sheng Chen, Dong-Hua Yang
oai:ojs2.www.bjbms.org:article/7782
2023-02-03T14:59:29Z
bjbms:COM
driver
Letter regarding “Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults”
Aktas, Gulali
non-HDL-C and triglyceride/HDL-C ratio
coronary plaque burden
plaque characteristics in young adults
letter to editor
Dear Editor:
I read with great interest the article by Akin et al., reporting an association between coronary plaque and serum lipid parameters. The authors examined serum lipid levels in patients undergoing computed tomography of the coronary arteries and reported that LDL cholesterol, total cholesterol, non-HDL cholesterol, triglycerides, and the ratio of triglycerides to HDL cholesterol were significantly higher in patients with coronary artery disease, and HDL cholesterol was significantly lower than in patients without coronary atherosclerosis. The results presented in the above study are consistent with data from the literature. Increased total and LDL cholesterol levels were found in patients with adequate coronary collateral development compared with patients with inadequate coronary collateral development.
Read more in PDF.
Association of Basic Medical Sciences of FBIH
2023-01-06
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/7782
10.17305/bjbms.2022.7782
Biomolecules and Biomedicine; Vol. 23 No. 1 (2023); 187
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/7782/2599
https://www.bjbms.org/ojs/index.php/bjbms/article/view/7782/2703
Copyright (c) 2022 Gulali Aktas
https://creativecommons.org/licenses/by/4.0
oai:ojs2.www.bjbms.org:article/9996
2024-01-03T19:15:06Z
bjbms:COM
driver
COP28 Open Letter on fossil fuels from the Global Medical and Health Community
Organisation Leadership, Global Health
in Health, Regional Leaders
Comments; open letter; fossil fuel; COP28
Dear COP28 President-Designate Sultan Ahmed Al-Jaber,
This year, world leaders gathering in the UAE to take stock of their climate commitments will for the first time engage in official programming focused on health. We, the signatories of this letter, support your leadership in bringing health to the forefront at COP28.
As global health leaders, we are committed to achieving health and well-being for all; this is not possible without a safe and stable climate. The Paris Agreement enshrined the “right to health” as a core obligation for climate action. Yet, communities, health workers and health systems around the world already face the alarming impacts of a changing climate. Climate change-induced extreme weather events are becoming more frequent and severe; many countries are grappling with the health consequences of extreme heat, unprecedented storms, floods, food and water insecurity, wildfires and displacement.
For COP28 to truly be a “health COP”, it must address the root cause of the climate crisis: the continued extraction and use of fossil fuels including coal, oil and gas. We call on the COP28 Presidency and the leaders of all countries to commit to an accelerated, just and equitable phase-out of fossil fuels as the decisive path to health for all.
Read more in the PDF.
Association of Basic Medical Sciences of FBIH
2024-01-03
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
text/xml
https://www.bjbms.org/ojs/index.php/bjbms/article/view/9996
10.17305/bb.2023.9996
Biomolecules and Biomedicine; Vol. 24 No. 1 (2024); 205–206
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/9996/3021
https://www.bjbms.org/ojs/index.php/bjbms/article/view/9996/3058
Copyright (c) 2023 Global Health Organisation Leadership, Regional Leaders in Health
https://creativecommons.org/licenses/by/4.0
oai:ojs2.www.bjbms.org:article/10233
2024-03-11T13:32:22Z
bjbms:COM
driver
Citation metrics and scientometrics
Igic, Rajko
Letter to Editor
scientometrics
citation metrics
I read the article “Scientometrics and academia” by Dr. Zerem and colleagues. My perspective on citation metrics and scientometrics is more cautious. Therefore, in this article, I present my viewpoint on this subject.
Read more in the PDF.
Association of Basic Medical Sciences of FBIH
2024-03-11
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
application/pdf
https://www.bjbms.org/ojs/index.php/bjbms/article/view/10233
10.17305/bb.2023.10233
Biomolecules and Biomedicine; Vol. 24 No. 2 (2024); 434–435
2831-090X
2831-0896
eng
https://www.bjbms.org/ojs/index.php/bjbms/article/view/10233/3115
Copyright (c) 2024 Rajko Igic
https://creativecommons.org/licenses/by/4.0